COCRYSTAL PHARMA, INC.
Ownership & governance
Executives 3Directors 6Avg age 71Avg tenure 5.2y
JS
James Sapirstein
Chief Executive Officer
Age 64Since 2026-06-02Profile →
+8
Executives3
JS
James Sapirstein→
Chief Executive Officer
Age 64Since 2026-06-02
JM
James Martin
Chief Executive Officer
Age 59Since 2021-05-26
SL
Sam Lee
Chief Executive Officer
Age 66Since 2021-05-26
Board of directors6
PF
Phillip Frost→
Director/Board Member
Age 88Since 2014-01-01
RK
Roger Kornberg→
Chairman
Age 79Since 2021-05-26
SR
Steven Rubin→
Director/Board Member
Age 65Since 2014-01-01
RP
Richard Pfenniger→
Director/Board Member
Age 70Since 2021-05-26
FH
Fred Hassan→
Director/Board Member
Age 80Since 2023-04-19
JS
James Sapirstein→
Director/Board Member
Age 64Since 2026-06-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Phillip Frost | 13.99 % | 1,928,876 |
| Fred Hassan | 10.02 % | 1,380,992 |
| Vanguard Capital Management LLC | 1.741 % | 239,971 |
| Renaissance Technologies LLC | 0.8988 % | 123,928 |
| Geode Capital Management LLC | 0.6544 % | 90,231 |
Catalog · 2026-07-09
Registry officers9
| Name | Role | Since | Shares |
|---|---|---|---|
| Roger Kornberg | Chairman | 2021-05-26 | - |
| Fred Hassan | Director/Board Member | 2023-04-19 | - |
| James Sapirstein | Director/Board Member | 2026-06-02 | - |
| Phillip Frost | Director/Board Member | 2014-01-01 | - |
| Richard Pfenniger | Director/Board Member | 2021-05-26 | - |
| Richard Pfenniger 78) | Director or executive officer | — | 87,550 |
| Roger Kornberg | Director or executive officer | — | 130,685 |
| Steven Rubin | Director or executive officer | — | 66,573 |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 8Range 6–10Analysts 3
6Mean 810
- Buy 2
Broker actions14
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | 6 | 2025-06-20 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2025-01-22 |
| HC Wainwright & Co. | Reiterated | Buy | 10 | 2024-05-14 |
| HC Wainwright & Co. | Reiterated | Buy | 10 | 2024-04-04 |
| HC Wainwright & Co. | Reiterated | Buy | 10 | 2024-03-20 |
| HC Wainwright & Co. | Maintained | Buy | 10 | 2024-01-03 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2023-12-04 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2023-10-04 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2023-08-15 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2023-08-11 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2023-06-02 |
| HC Wainwright & Co. | Maintained | Buy | 12 | 2023-05-24 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.